UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in OLMA — Olema Pharmaceuticals, Inc.

CIK 861177 NEW YORK, NY

Back to OLMA Full portfolio

Position in OLMA

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$614,691

+$241,569 QoQ

Shares Held

49,136

+96.3% QoQ

Ownership

0.056%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#94

of 182 holders

Holding Since

Dec 2023

8 quarters on record

Voting authority Sole 38% Shared 0% None 62%

Common Shares in OLMA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. OLMA ranks #129 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,086,683	$1,533,248,041
2	REGN	Regeneron Pharmaceuticals, Inc.	716,560	$446,803,817
3	ALNY	Alnylam Pharmaceuticals, Inc.	727,848	$219,104,078
4	INCY	Incyte Corp	1,508,720	$171,028,494
5	RVMD	Revolution Medicines, Inc.	912,335	$170,862,094
6	INSM	INSMED Inc	1,335,071	$142,345,265
7	IONS	Ionis Pharmaceuticals Inc	1,454,672	$115,340,938
8	MRNA	Moderna, Inc.	1,521,849	$106,575,080

All Filings in OLMA

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$614,691	49,136	+96.3%	Shares	Defined	2026-08-13
2026-03-31	$373,122	25,025	+5974.0%	Shares	Defined	2026-05-13
2025-12-31	$10,300	412	-99.6%	Shares	Defined	2026-02-13
2024-12-31	$547,896	93,979	+23.7%	Shares	Sole	2025-02-14
2024-09-30	$907,129	75,974	-9.1%	Shares	Defined	2024-11-14
2024-06-30	$904,443	83,590	+190.3%	Shares	Defined	2024-08-14
2024-03-31	$325,902	28,790	+34.7%	Shares	Defined	2024-05-15
2023-12-31	$299,932	21,378	—	Shares	Defined	2024-02-14
No filing history on record for this holder in this stock.